SCHEMBL312259

SCHEMBL312259

CCOC(=O)Nc1cc(O)ccc1-c1cc(=O)c2ncc(O)cc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.40
AKR1B1 P15121 1/20 0.39
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TYR P14679 1/20 0.37
PTPN1 P18031 1/20 0.37
PTGS1 P23219 1/20 0.37
BACE1 P56817 1/20 0.37
PTPN12 Q05209 1/20 0.37
PTPN22 Q9Y2R2 1/20 0.37
XDH P47989 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MIF P14174 2/20 0.36
PFKFB3 Q16875 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL311757 0.88 MAOB (0.39) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL311135 0.87 MAOB (0.44) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL313600 0.86 MAOB (0.41) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL312452 0.84 MAOB (0.39) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL312223 0.84 AKR1B1 (0.56) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL311904 0.84 HPGD (0.40) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL312716 0.84 MAOB (0.43) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL311620 0.83 AKR1B1 (0.43) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL312670 0.83 HPGD (0.42) MAOBAKR1B1KDM4EHPGDHSD17B10
SCHEMBL312054 0.83 MAOB (0.39) MAOBAKR1B1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed